Novo Nordisk, the maker of the popular weight loss drug Wegovy, and OpenAI, known for its AI chatbot ChatGPT, are partnering to accelerate the search for new medications.
The Danish drug manufacturer announced the partnership in a Tuesday press release, noting that the goal was to bring “new and better treatment options to patients faster.”